← Back to Search

Procedure

Boron Neutron Capture Therapy for Skin Cancer

Phase 1

Waitlist Available

Research Sponsored by Beth Israel Deaconess Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Grossly evident cutaneous or subcutaneous tumor nodules are eligible for irradiation

Age: 18 and over

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is studying boron neutron capture therapy to see how well it works in treating patients with stage III melanoma.

Who is the study for?

This trial is for adults over 18 with stage III melanoma, where the cancerous area is visible and not larger than 10 cm across. Participants must be relatively healthy (Karnofsky score of at least 70%), expected to live more than three months, and have a tumor depth between 1.0-6.0 cm from the skin surface. Pregnant women or those who can't use effective birth control are excluded.Check my eligibility

What is being tested?

The study is testing Boron Neutron Capture Therapy (BNCT) on patients with stage III melanoma to see if it can kill cancer cells while sparing healthy tissue. This phase I trial aims to determine the therapy's effectiveness specifically for this advanced skin cancer condition.See study design

What are the potential side effects?

While specific side effects for BNCT in this trial aren't listed, common ones may include redness or swelling of the skin, blistering or peeling at treatment sites, fatigue, and potential damage to nearby normal tissues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have visible skin or just under the skin tumor nodules that can be treated with radiation.

Select...

I am 18 years old or older.

Select...

My tumor is between 1.0 and 6.0 cm deep from the skin surface.

Select...

My tumor is 10 cm or smaller in size.

Select...

My melanoma is confirmed by biopsy and is at stage III.

Select...

I am mostly able to care for myself and carry out daily activities.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

0 / 6Eligibility criteria met

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor

836 Previous Clinical Trials

13,010,321 Total Patients Enrolled

Paul M. Busse, MD, PhDStudy ChairBeth Israel Deaconess Medical Center

2 Previous Clinical Trials

Media Library

Boron Neutron Capture Therapy (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT00002781 — Phase 1

Skin Cancer Clinical Trial 2023: Boron Neutron Capture Therapy Highlights & Side Effects. Trial Name: NCT00002781 — Phase 1

Boron Neutron Capture Therapy (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00002781 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still available spots in this trial for interested participants?

"Querying clinicaltrials.gov reveals that this particular medical trial is not actively accepting patients at the moment, with an initial post date of April 1st 1996 and a recent edit on September 16th 2013. However, there are 757 other trials currently seeking participants for involvement."

Answered by AI